Wall Street Analysts Look Bullish on CleanSpark (CLSK): Should You Buy? — Positive
CLSK Zacks Investment Research — July 31, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Exelon (EXC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
EXC Zacks Investment Research — July 31, 2025Although the revenue and EPS for Exelon (EXC) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Should You Invest in Alibaba (BABA) Based on Bullish Wall Street Views? — Positive
BABA Zacks Investment Research — July 31, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Anheuser-Busch Inbev (BUD) Reports Q2 Earnings: What Key Metrics Have to Say — Neutral
BUD Zacks Investment Research — July 31, 2025While the top- and bottom-line numbers for Anheuser-Busch Inbev (BUD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Upbound Group (UPBD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
UPBD Zacks Investment Research — July 31, 2025Although the revenue and EPS for Upbound Group (UPBD) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Here's What Key Metrics Tell Us About CyberArk (CYBR) Q2 Earnings — Positive
CYBR Zacks Investment Research — July 31, 2025Although the revenue and EPS for CyberArk (CYBR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Agco (AGCO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Neutral
AGCO Zacks Investment Research — July 31, 2025While the top- and bottom-line numbers for Agco (AGCO) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Shake Shack (SHAK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
SHAK Zacks Investment Research — July 31, 2025The headline numbers for Shake Shack (SHAK) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
APi (APG) Reports Q2 Earnings: What Key Metrics Have to Say — Positive
APG Zacks Investment Research — July 31, 2025The headline numbers for APi (APG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Neutral
BAX Zacks Investment Research — July 31, 2025While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Xcel (XEL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
XEL Zacks Investment Research — July 31, 2025The headline numbers for Xcel (XEL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Lincoln National (LNC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
LNC Zacks Investment Research — July 31, 2025The headline numbers for Lincoln National (LNC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Masco (MAS) Reports Q2 Earnings: What Key Metrics Have to Say — Neutral
MAS Zacks Investment Research — July 31, 2025While the top- and bottom-line numbers for Masco (MAS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
CVS Health (CVS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
CVS Zacks Investment Research — July 31, 2025Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Janus Henderson Group (JHG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
JHG Zacks Investment Research — July 31, 2025The headline numbers for Janus Henderson Group (JHG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ICE (ICE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
ICE Zacks Investment Research — July 31, 2025Although the revenue and EPS for ICE (ICE) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
S&P Global (SPGI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates — Neutral
SPGI Zacks Investment Research — July 31, 2025While the top- and bottom-line numbers for S&P Global (SPGI) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MGP (MGPI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
MGPI Zacks Investment Research — July 31, 2025Although the revenue and EPS for MGP (MGPI) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Apellis Pharmaceuticals (APLS) Reports Q2 Earnings: What Key Metrics Have to Say — Positive
APLS Zacks Investment Research — July 31, 2025The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Hilton Grand Vacations (HGV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
HGV Zacks Investment Research — July 31, 2025Although the revenue and EPS for Hilton Grand Vacations (HGV) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
